Acute and chronic effects of clozapine on cholinergic transmission in cultured mouse superior cervical ganglion neurons

References

• Addy, N., & Levin, E.D. (2002). Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats. Neuropsychopharmacology, 27, 534–541. doi:10.1016/s0893-133x(02)00327-5.
   PubMed Web of Science ®Google Scholar
• Alexander, K.S., Brooks, J.M., Sarter, M., & Bruno, J.P. (2009). Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment. Neuropsychopharmacology, 34, 2710–2720. doi:10.1038/npp.2009.105.
   PubMed Web of Science ®Google Scholar
• Alkondon, M., Pereira, E.F., & Albuquerque, E.X. (1998). Alpha-bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Research, 810, 257–263. doi:10.1016/S0006-8993(98)00880-4.
   PubMed Web of Science ®Google Scholar
• Blennerhassett, M.G., & Bienenstock, J. (1998). Sympathetic nerve contact causes maturation of mast cells in vitro. Journal of Neurobiology, 35, 173–182. doi:10.1002/(SICI)1097-4695(199805)35:2<173::AID-NEU4>3.0.CO;2-1.
   PubMedGoogle Scholar
• Boucher, S.D., & Katz, N.L. (1977). Effects of several 'membrane stabilizing' agents on frog neuromuscular junction. European Journal of Pharmacology, 42, 139–145. doi:10.1016/0014-2999(77)90353-3.
   PubMed Web of Science ®Google Scholar
• Broich, K., Heinrich, S., & Marneros, A. (1998). Acute clozapine overdose: plasma concentration and outcome. Pharmacopsychiatry, 31, 149–151. doi:10.1055/s-2007-979318.
   PubMed Web of Science ®Google Scholar
• Chang, W.H., Lin, S.K., Lane, H.Y., Hu, W.H., Jann, M.W., & Lin, H.N. (1997). Clozapine dosages and plasma drug concentrations. Journal of the Formosan Medical Association, 96, 599–605.
   PubMed Web of Science ®Google Scholar
• Cheng, K.C., Lambert, J.J., Henderson, E.G., Smilowitz, H., & Epstein, P.M. (1981). Postsynaptic inhibition of neuromuscular transmission by trifluoperazine. Journal of Pharmacology and Experimental Therapeutics, 217, 44–50.
   PubMed Web of Science ®Google Scholar
• Chung, Y.C., Li, Z., Dai, J., Meltzer, H.Y., & Ichikawa, J. (2004). Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism. Brain Research, 1023, 54–63. doi:10.1016/j.brainres.2004.07.009.
   PubMed Web of Science ®Google Scholar
• Critchlow, H.M., Maycox, P.R., Skepper, J.N., & Krylova, O. (2006). Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons. Molecular and Cellular Neuroscience, 32, 356–365. doi:10.1016/j.mcn.2006.05.007.
   PubMed Web of Science ®Google Scholar
• Cummings, J.L., & Benson, D.F. (1987). The role of the nucleus basalis of Meynert in dementia: review and reconsideration. Alzheimer Disease and Associated Disorders, 1, 128–155. doi:10.1097/00002093-198701030-00003.
   PubMedGoogle Scholar
• Daly, J.W. (2005). Nicotinic agonists, antagonists, and modulators from natural sources. Cellular and Molecular Neurobiology, 25, 513–552. doi:10.1007/s10571-005-3968-4.
   PubMed Web of Science ®Google Scholar
• De Koninck, P., & Cooper, E. (1995). Differential regulation of neuronal nicotinic ACh receptor subunit genes in cultured neonatal rat sympathetic neurons: specific induction of alpha 7 by membrane depolarization through a Ca2+/calmodulin-dependent kinase pathway. Journal of Neuroscience, 15, 7966–7978.
   PubMed Web of Science ®Google Scholar
• Deutsch, J.A. (1971). The cholinergic synapse and the site of memory. Science, 174, 788–794. doi:10.1126/science.174.4011.788.
   PubMed Web of Science ®Google Scholar
• Dong, E., Nelson, M., Grayson, D.R., Costa, E., & Guidotti, A. (2008). Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proceedings of the National Academy of Sciences USA, 105, 13614–13619. doi:10.1073/pnas.0805493105.
   PubMed Web of Science ®Google Scholar
• Featherstone, R.E., & Siegel, S.J. (2015). The role of nicotine in schizophrenia. International Review of Neurobiology, 124, 23–78. doi:10.1016/bs.irn.2015.07.002.
   PubMed Web of Science ®Google Scholar
• Freedman, R., Olincy, A., Buchanan, R.W., Harris, J.G., Gold, J.M., Johnson, L., … Kem, W.R. (2008). Initial phase 2 trial of a nicotinic agonist in schizophrenia. American Journal of Psychiatry, 165, 1040–1047. doi:10.1176/appi.ajp.2008.07071135.
   PubMed Web of Science ®Google Scholar
• Gibbons, A., & Dean, B. (2016). The cholinergic system: an emerging drug target for schizophrenia. Current Pharmaceutical Design, 22, 2124–2133. doi:10.2174/1381612822666160127114010.
   PubMed Web of Science ®Google Scholar
• Gray, J.A., & Roth, B.L. (2007). The pipeline and future of drug development in schizophrenia. Molecular Psychiatry, 12, 904–922. doi:10.1038/sj.mp.4002062.
   PubMed Web of Science ®Google Scholar
• Grinevich, V.P., Papke, R.L., Lippiello, P.M., & Bencherif, M. (2009). Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors. Neuropharmacology, 57, 183–191. doi:10.1016/j.neuropharm.2009.05.003.
   PubMed Web of Science ®Google Scholar
• Guidotti, A., & Grayson, D.R. (2014). DNA methylation and demethylation as targets for antipsychotic therapy. Dialogues in Clinical Neuroscience, 16, 419–429.
   PubMed Web of Science ®Google Scholar
• Hagger, C., Buckley, P., Kenny, J.T., Friedman, L., Ubogy, D., & Meltzer, H.Y. (1993). Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry, 34, 702–712. doi:10.1016/0006-3223(93)90043-d.
   PubMed Web of Science ®Google Scholar
• Halene, T.B., Kozlenkov, A., Jiang, Y., Mitchell, A.C., Javidfar, B., Dincer, A., … Akbarian, S. (2016). NeuN(+) neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure. Schizophrenia Research, 170, 235–244. doi:10.1016/j.schres.2015.12.016.
   PubMed Web of Science ®Google Scholar
• Harrison, P.J., & Weinberger, D.R. (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry, 10, 40–68; image 45. doi:10.1038/sj.mp.4001558.
   PubMed Web of Science ®Google Scholar
• Hasegawa, M., Gutierrez-Esteinou, R., Way, L., & Meltzer, H.Y. (1993). Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. Journal of Clinical Psychopharmacology, 13, 383–390. doi:10.1097/00004714-199312000-00003.
   PubMed Web of Science ®Google Scholar
• Ichikawa, J., Dai, J., O'laughlin, I.A., Fowler, W.L., & Meltzer, H.Y. (2002). Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology, 26, 325–339. doi:10.1016/s0893-133x(01)00312-8.
   PubMed Web of Science ®Google Scholar
• Johnson, D.E., Nedza, F.M., Spracklin, D.K., Ward, K.M., Schmidt, A.W., Iredale, P.A., … Rollema, H. (2005). The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release. European Journal of Pharmacology, 506, 209–219. doi:10.1016/j.ejphar.2004.11.015.
   PubMed Web of Science ®Google Scholar
• Koh, D.S., & Hille, B. (1997). Modulation by neurotransmitters of catecholamine secretion from sympathetic ganglion neurons detected by amperometry. Proceedings of the National Academy of Sciences USA, 94, 1506–1511. doi:10.1073/pnas.94.4.1506.
   PubMed Web of Science ®Google Scholar
• Krapivinsky, G., Mochida, S., Krapivinsky, L., Cibulsky, S.M., & Clapham, D.E. (2006). The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron, 52, 485–496. doi:10.1016/j.neuron.2006.09.033.
   PubMed Web of Science ®Google Scholar
• Lewis, A.S., & Picciotto, M.R. (2013). High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness. Psychopharmacology (Berl), 229, 477–485. doi:10.1007/s00213-013-3126-5.
   PubMed Web of Science ®Google Scholar
• Luther, J.A., Enes, J., & Birren, S.J. (2013). Neurotrophins regulate cholinergic synaptic transmission in cultured rat sympathetic neurons through a p75-dependent mechanism. Journal of Neurophysiology, 109, 485–496. doi:10.1152/jn.00076.2011.
   PubMed Web of Science ®Google Scholar
• Ma, H., & Mochida, S. (2007). A cholinergic model synapse to elucidate protein function at presynaptic terminals. Neuroscience Research, 57, 491–498. doi:10.1016/j.neures.2006.12.015.
   PubMed Web of Science ®Google Scholar
• Martin, L.F., & Freedman, R. (2007). Schizophrenia and the alpha7 nicotinic acetylcholine receptor. International Review of Neurobiology, 78, 225–246. doi:10.1016/s0074-7742(06)78008-4.
   PubMed Web of Science ®Google Scholar
• McGurk, S.R. (1999). The effects of clozapine on cognitive functioning in schizophrenia. Journal of Clinical Psychiatry, 60(Suppl 12), 24–29.
   PubMed Web of Science ®Google Scholar
• Meltzer, H.Y., & McGurk, S.R. (1999). The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin, 25, 233–255. doi:10.1093/oxfordjournals.schbul.a033376.
   PubMed Web of Science ®Google Scholar
• Mochida, S., Nonomura, Y., & Kobayashi, H. (1994). Analysis of the mechanism for acetylcholine release at the synapse formed between rat sympathetic neurons in culture. Microscopy Research and Technique, 29, 94–102. doi:10.1002/jemt.1070290206.
   PubMed Web of Science ®Google Scholar
• Nai, Q., Wang, X., Jin, Y., Sun, D., Li, M., Hu, B., Zhang, X. (2010). Ciliary neurotrophic factor enhances nicotinic synaptic transmission in sympathetic neurons. Journal of Neuroscience Research, 88, 887–895. doi:10.1002/jnr.22260.
   PubMed Web of Science ®Google Scholar
• Nguyen, Q.T., & Miledi, R. (2002). Inhibition of skeletal muscle nicotinic receptors by the atypical antipsychotic clozapine. Neuropharmacology, 42, 662–669. doi:10.1016/S0028-3908(02)00017-5.
   PubMed Web of Science ®Google Scholar
• Ochoa, E.L., & Lasalde-Dominicci, J. (2007). Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking. Cellular and Molecular Neurobiology, 27, 609–639. doi:10.1007/s10571-007-9149-x.
   PubMed Web of Science ®Google Scholar
• Olincy, A., & Freedman, R. (2012). Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the alpha7 nicotinic receptor. Handbook of Experimental Pharmacology, 213, 211–232. doi:10.1007/978-3-642-25758-2_8.
   PubMedGoogle Scholar
• Park, T., Bae, S., Choi, S., Kang, B., & Kim, K. (2001). Inhibition of nicotinic acetylcholine receptors and calcium channels by clozapine in bovine adrenal chromaffin cells. Biochemical Pharmacology, 61, 1011–1019. doi:10.1016/S0006-2952(01)00577-9.
   PubMed Web of Science ®Google Scholar
• Perry, P.J., Miller, D.D., Arndt, S.V., & Cadoret, R.J. (1991). Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. American Journal of Psychiatry, 148, 231–235. doi:10.1176/ajp.148.2.231.
   PubMed Web of Science ®Google Scholar
• Rezvani, A.H., & Levin, E.D. (2004). Nicotine-antipsychotic drug interactions and attentional performance in female rats. European Journal of Pharmacology, 486, 175–182. doi:10.1016/j.ejphar.2003.12.021.
   PubMed Web of Science ®Google Scholar
• Ripoll, N., Bronnec, M., & Bourin, M. (2004). Nicotinic receptors and schizophrenia. Current Medical Research and Opinion, 20, 1057–1074. doi:10.1185/030079904125004060.
   PubMed Web of Science ®Google Scholar
• Sahaf, Z.Y., & Publicover, S.J. (1986). Postsynaptic inhibitory effects of phenothiazines at cholinergic synapses may not involve calmodulin. Naunyn-Schmiedeberg’s Archives of Pharmacology, 333, 454–456. doi:10.1007/BF00500024.
   PubMed Web of Science ®Google Scholar
• Sarter, M., & Parikh, V. (2005). Choline transporters, cholinergic transmission and cognition. Nature Reviews Neuroscience, 6, 48–56. doi:10.1038/nrn1588.
   PubMed Web of Science ®Google Scholar
• Schliebs, R., & Arendt, T. (2011). The cholinergic system in aging and neuronal degeneration. Behavioural Brain Research, 221, 555–563. doi:10.1016/j.bbr.2010.11.058.
   PubMed Web of Science ®Google Scholar
• Seeman, P., & Van Tol, H.H. (1994). Dopamine receptor pharmacology. Trends in Pharmacological Sciences, 15, 264–270. doi:10.1016/0165-6147(94)90323-9.
   PubMed Web of Science ®Google Scholar
• Shen, E., Shulha, H., Weng, Z., & Akbarian, S. (2014). Regulation of histone H3K4 methylation in brain development and disease. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 369, 20130514. doi:10.1098/rstb.2013.0514.
   Web of Science ®Google Scholar
• Shirazi-Southall, S., Rodriguez, D.E., & Nomikos, G.G. (2002). Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology, 26, 583–594. doi:10.1016/s0893-133x(01)00400-6.
   PubMed Web of Science ®Google Scholar
• Singhal, S.K., Zhang, L., Morales, M., & Oz, M. (2007). Antipsychotic clozapine inhibits the function of alpha7-nicotinic acetylcholine receptors. Neuropharmacology, 52, 387–394. doi:10.1016/j.neuropharm.2006.08.023.
   PubMed Web of Science ®Google Scholar
• Stahl, S.M. (1999). Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials. Journal of Clinical Psychiatry, 60(Suppl 10), 31–41.
   PubMed Web of Science ®Google Scholar
• Wonnacott, S., Barik, J., Dickinson, J., & Jones, I.W. (2006). Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters. Journal of Molecular Neuroscience, 30, 137–140. doi:10.1385/jmn:30:1:137.
   PubMed Web of Science ®Google Scholar